# OnCo record next-gen-short-read-platforms (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/next-gen-short-read-platforms/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "next-gen-short-read-platforms" ;
  schema:name "New short-read sequencing platforms"@en ;
  schema:description "New short-read sequencing platforms from Ultima Genomics, Element Biosciences, Roche and MGI compete with Illumina by cutting the cost per gigabase, with Ultima claiming a genome under 100 dollars. Cheaper reads make whole-genome tumour-normal sequencing and deep ctDNA testing affordable in principle, but clinical assays must be revalidated and Illumina's installed base still dominates."@en ;
  schema:url <https://onco.cc/technologies/next-gen-short-read-platforms/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1101/2022.05.29.493900> ;
  onco:status "emerging" ;
  onco:tag "supporting" ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/wes-wgs/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/illumina/>, <https://onco.cc/companies/ultima-genomics/>, <https://onco.cc/companies/element-biosciences/>, <https://onco.cc/companies/roche-genentech/>, <https://onco.cc/companies/mgi-tech/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-almogy-biorxiv/> .